here. Its strong growth and conservative financing both seem like plusses to me. Almost the reverse of Aligent, Thermo Fisher has weak returns on its equity base, but has the second-strongest growth component in the field. Though its EBIT margin leaves...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Does Agilent Technologies Deserve a Spot in Your Portfolio?
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account